Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 2378626-29-8 Chemical Structure| 2378626-29-8

Structure of TED-347
CAS No.: 2378626-29-8

Chemical Structure| 2378626-29-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TED-347 is a potent, irreversible, covalent and allosteric inhibitor of the TEAD-Yap protein-protein interaction. TED-347 inhibits TEAD4-Yap1 interaction with an EC50 value of 5.9 μM.

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TED-347

CAS No. :2378626-29-8
Formula : C15H11ClF3NO
M.W : 313.70
SMILES Code : FC(C1=CC(NC2=CC=CC=C2C(CCl)=O)=CC=C1)(F)F
English Name :2-Chloro-1-(2-((3-(trifluoromethyl)phenyl)amino)phenyl)ethanone
MDL No. :MFCD32689460
InChI Key :JPVDFGYNLUBCSD-UHFFFAOYSA-N
Pubchem ID :137796964

Safety of TED-347

Related Pathways of TED-347

Hippo

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
PANC-1 cells 10 μM Detect mRNA expression levels of CTGF and CYR61 J Exp Clin Cancer Res. 2021 Mar 1;40(1):88.
BxPC-3 cells 10 μM Detect mRNA expression levels of CTGF and CYR61 J Exp Clin Cancer Res. 2021 Mar 1;40(1):88.
MIA PaCa-2 cells 10 μM Detect mRNA expression levels of CTGF and CYR61 J Exp Clin Cancer Res. 2021 Mar 1;40(1):88.
KYSE-30 cells 10 µm 48 hours To evaluate the effect of TED-347 on the proliferation, migration, and invasion of KYSE-30 cells after inhibition of the TEAD4/YAP1 complex. Results showed that TED-347 significantly inhibited the promoting effect of TEAD4 overexpression on the malignant behaviors of ESCC cells. Bioengineered. 2021 Dec;12(1):601-614.
PDLSCs 5 µM 24 hours To investigate the effect of TED-347 on the mechanical force-induced elevation of the RANKL/OPG ratio, it was found that TED-347 partly attenuated the mechanical force-induced elevation of the RANKL/OPG ratio. Prog Orthod. 2024 Aug 12;25(1):29.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Pancreatic cancer xenograft model 20 mg/kg 3 times, on days 1, 4, and 7 Evaluate the inhibitory effect of TED-347 on tumor growth J Exp Clin Cancer Res. 2021 Mar 1;40(1):88.
NOD-SCID mice Esophageal squamous cell carcinoma lung metastasis model Oral 20 mg/kg Every other day for three cycles Evaluate the inhibitory effect of TED-347 on early implantation and lung metastasis Nat Commun. 2024 Nov 16;15(1):9950

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.19mL

0.64mL

0.32mL

15.94mL

3.19mL

1.59mL

31.88mL

6.38mL

3.19mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories